Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the business’s stock in a transaction dated Thursday, March 30th. The stock was sold at an average price of $217.14, for a total transaction of $1,737,120.00. Following the transaction, the chief executive officer now owns 130 shares in the company, […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the stock in a transaction that occurred on Friday, March 24th. The stock was sold at an average price of $217.95, for a total transaction of $1,743,600.00. Following the completion of the sale, the chief executive officer now directly owns […]
Maryland State Retirement & Pension System bought a new stake in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) during the fourth quarter, HoldingsChannel.com reports. The firm bought 3,506 shares of the biotechnology company’s stock, valued at approximately $975,000. Several other hedge funds and other institutional investors also recently modified their holdings of UTHR. Wellington Management […]
Cardinal Capital Management lifted its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 1.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,988 shares of the biotechnology company’s stock after buying an additional 85 shares during the quarter. Cardinal […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the company’s stock in a transaction dated Monday, March 27th. The shares were sold at an average price of $217.04, for a total value of $1,736,320.00. Following the sale, the chief executive officer now owns 130 shares in the company, […]